Periprocedural management of new oral anticoagulants in patients undergoing atrial fibrillation ablation.
Departments of Medicine and Biochemistry, McMaster University, and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada (J.I.W.); the Department of Medicine, McMaster University, and Population Health Research Institute, Hamilton, Ontario, Canada (J.S.H.); the Department of Medicine, Western University, London, Ontario, Canada (A.C.S.); and the Department of Medicine, University of Toronto, Toronto, Ontario, Canada (A.V.).
- Published Article
Ovid Technologies Wolters Kluwer -American Heart Association
- Publication Date
Apr 22, 2014
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 06/09/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/24753548